These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 24909331

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Local and systemic immune responses induced by a recombinant chimeric protein containing Mycoplasma hyopneumoniae antigens fused to the B subunit of Escherichia coli heat-labile enterotoxin LTB.
    Marchioro SB, Fisch A, Gomes CK, Jorge S, Galli V, Haesebrouck F, Maes D, Dellagostin O, Conceição FR.
    Vet Microbiol; 2014 Sep 17; 173(1-2):166-71. PubMed ID: 25091529
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A recombinant chimera composed of R1 repeat region of Mycoplasma hyopneumoniae P97 adhesin with Escherichia coli heat-labile enterotoxin B subunit elicits immune response in mice.
    Conceição FR, Moreira AN, Dellagostin OA.
    Vaccine; 2006 Jul 17; 24(29-30):5734-43. PubMed ID: 16730864
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immune responses elicited by Mycoplasma hyopneumoniae recombinant antigens and DNA constructs with potential for use in vaccination against porcine enzootic pneumonia.
    Virginio VG, Gonchoroski T, Paes JA, Schuck DC, Zaha A, Ferreira HB.
    Vaccine; 2014 Oct 07; 32(44):5832-8. PubMed ID: 25148775
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Shedding reduction and immunity modulation in piglets with an inactivated Mycoplasma hyopneumoniae vaccine encapsulated in nanostructured SBA-15 silica.
    Petri FAM, Malcher CS, Mechler-Dreibi ML, Panneitz AK, Braga ER, Aguiar GA, Toledo LT, Martins TS, Cides-da-Silva LC, Fantini MCA, Sant'Anna OA, Montassier HJ, Oliveira LG.
    Vaccine; 2024 Oct 24; 42(24):126268. PubMed ID: 39208565
    [Abstract] [Full Text] [Related]

  • 14. Immune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin.
    Okamba FR, Moreau E, Cheikh Saad Bouh K, Gagnon CA, Massie B, Arella M.
    Clin Vaccine Immunol; 2007 Jun 24; 14(6):767-74. PubMed ID: 17409219
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vivo and in vitro comparisons of spray-drying and solvent- evaporation preparation of microencapsulated Mycoplasma hyopneumoniae for use as an orally administered vaccine for pigs.
    Lin JH, Pan MJ, Liao CW, Weng CN.
    Am J Vet Res; 2002 Aug 24; 63(8):1118-23. PubMed ID: 12171164
    [Abstract] [Full Text] [Related]

  • 19. Co-administration of attenuated Mycoplasma hyopneumoniae 168 strain with bacterial DNA enhances the local and systemic immune response after intranasal vaccination in pigs.
    Li Y, Li P, Wang X, Yu Q, Yang Q.
    Vaccine; 2012 Mar 09; 30(12):2153-8. PubMed ID: 22266290
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains.
    Michiels A, Arsenakis I, Boyen F, Krejci R, Haesebrouck F, Maes D.
    BMC Vet Res; 2017 Aug 29; 13(1):274. PubMed ID: 28851359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.